Date | Company | Who recommends | Recommendation | Target price |
---|---|---|---|---|
Johnson & Johnson | Deutsche Bank | Buy | 105 | |
Endo International plc | Deutsche Bank | Buy | 88 | |
Becton, Dickinson and Company | Deutsche Bank | Buy | 167 | |
CVS Health Corporation | Deutsche Bank | Buy | 118 | |
Pfizer Inc. | Morgan Stanley | Buy | 43 | |
Bristol-Myers Squibb Company | Morgan Stanley | Buy | 80 | |
DENTSPLY International Inc. | Morgan Stanley | Buy | 70 | |
UnitedHealth Group Incorporated | Morgan Stanley | Buy | 140 | |
Anthem, Inc. | RBC Capital Mkts | Buy | 198 | |
Edwards Lifesciences Corp. | RBC Capital Mkts | Buy | 160 | |
DaVita HealthCare Partners Inc. | RBC Capital Mkts | Buy | 83 | |
Express Scripts Holding Company | RBC Capital Mkts | Buy | 95 | |
HCA Holdings, Inc. | UBS | Buy | 90 | |
AbbVie Inc. | UBS | Buy | 78 | |
Merck & Co. Inc. | UBS | Buy | 68 | |
Celgene Corporation | UBS | Buy | 156 | |
Alexion Pharmaceuticals, Inc. | UBS | Buy | 223 | |
PerkinElmer Inc. | UBS | Buy | 60 |